| A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. NJ Miller, C Rice-Evans, MJ Davies, V Gopinathan, A Milner Clinical science (London, England: 1979) 84 (4), 407-412, 1993 | 4215 | 1993 |
| Management of hyperglycemia in Type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, DA D’Alessio, J Fradkin, WN Kernan, C Mathieu, G Mingrone, ... | 4092 | 2018 |
| Type 2 diabetes S Chatterjee, K Khunti, MJ Davies The lancet 389 (10085), 2239-2251, 2017 | 2631 | 2017 |
| Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. BSJ Wilmot EG, Edwardson CL, Achana FA, Davies MJ, Gorely T, Gray LJ, Khunti ... Diabetologia 55 (11), 2895-905, 2012 | 2249 | 2012 |
| Effect of Rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. TDT Investigators. Lancet 368 (9541), 1096-1105, 2006 | 2225* | 2006 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1829* | 2021 |
| Once-weekly semaglutide in adults with overweight or obesity JPH Wilding, RL Batterham, S Calanna, M Davies, LF Van Gaal, I Lingvay, ... New England Journal of Medicine 384 (11), 989-1002, 2021 | 1816 | 2021 |
| 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study … DMJ Buse J, Wexler D, Tsapas A, Rossing P, Mingrone G, Mathieu C, D'Alessio D Diabetes Care, 2019 | 1762* | 2019 |
| The prevalence of co‐morbid depression in adults with Type 2 diabetes: a systematic review and meta‐analysis S Ali, MA Stone, JL Peters, MJ Davies, K Khunti Diabetic medicine 23 (11), 1165-1173, 2006 | 1662 | 2006 |
| Effect of valsartan on the incidence of diabetes and cardiovascular events NAVIGATOR Study Group New England Journal of Medicine 362 (16), 1477-1490, 2010 | 1349* | 2010 |
| n-3 Fatty Acids and cardiovascular outcomes in patients with dysglycemia O Investigators New England Journal of Medicine 367 (4), 309-318, 2012 | 1095 | 2012 |
| Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis P Carter, LJ Gray, J Troughton, K Khunti, MJ Davies Bmj 341, 2010 | 1036 | 2010 |
| Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster … MJ Davies, S Heller, TC Skinner, MJ Campbell, ME Carey, S Cradock, ... Bmj 336 (7642), 491-495, 2008 | 1022* | 2008 |
| Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial MJ Davies, R Bergenstal, B Bode, RF Kushner, A Lewin, TV Skjøth, ... Jama 314 (7), 687-699, 2015 | 977 | 2015 |
| Effect of Ramipril on the Incidence of Diabetes TDT Investigators New England Journal of Medicine 355 (15), 1551-1562, 2006 | 970* | 2006 |
| Effect of valsartan on the incidence of diabetes and cardiovascular events NAVIGATOR Study Group New England Journal of Medicine 362 (16), 1477-1490, 2010 | 931 | 2010 |
| Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes RR Holman, KI Thorne, AJ Farmer, MJ Davies, JF Keenan, S Paul, ... New England Journal of Medicine 357 (17), 1716-1730, 2007 | 929 | 2007 |
| A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with … K Hermansen, M Davies, T Derezinski, G Martinez Ravn, P Clauson, ... Diabetes care 29 (6), 1269-1274, 2006 | 918 | 2006 |
| Three-year efficacy of complex insulin regimens in type 2 diabetes RR Holman, AJ Farmer, MJ Davies, JC Levy, JL Darbyshire, JF Keenan, ... New England Journal of Medicine 361 (18), 1736-1747, 2009 | 883 | 2009 |
| Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes JP Frías, MJ Davies, J Rosenstock, FC Pérez Manghi, L Fernández Landó, ... New England Journal of Medicine 385 (6), 503-515, 2021 | 850 | 2021 |
Kamlesh KhuntiProfessor of Primary Care Diabetes and Vascular Medicine, University of LeicesterПодтвержден адрес электронной почты в домене le.ac.uk
